21 CFR 14.30
§ 14.30 Chairperson of an advisory committee.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 14.30, § 14.30 Chairperson of an advisory committee, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/83174
- Permanent ID
ys:prov:83174@1- SHA-256
baca90fce009200c5023b200b2064e29c54c13d0f274beddc538f4930b3e1995
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) The advisory committee Chairperson has the authority to conduct hearings and meetings, including the authority to adjourn a hearing or meeting if the Chairperson determines that adjournment is in the public interest, to discontinue discussion of a matter, to conclude the open portion of a meeting, or to take any other action to further a fair and expeditious hearing or meeting.
(b) If the Chairperson is not a full-time employee of FDA, the Designated Federal Officer or other designated agency employee, or alternate, is to be the designated Federal employee who is assigned to the advisory committee. The designated Federal employee is also authorized to adjourn a hearing or meeting if the employee determines adjournment to be in the public interest.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.